Michael Mason

2021

In 2021, Michael Mason earned a total compensation of $1.7M as Executive Vice President, Chief Financial Officer and Treasurer at Karyopharm Therapeutics, a 23% decrease compared to previous year.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$182,000
Option Awards$681,352
Salary$444,386
Stock Awards$370,834
Other$16,006
Total$1,744,578

Mason received $681.4K in option awards, accounting for 39% of the total pay in 2021.

Mason also received $50K in bonus, $182K in non-equity incentive plan, $444.4K in salary, $370.8K in stock awards and $16K in other compensation.

Rankings

In 2021, Michael Mason's compensation ranked 6,601st out of 12,415 executives tracked by ExecPay. In other words, Mason earned more than 46.8% of executives.

ClassificationRankingPercentile
All
6,601
out of 12,415
47th
Division
Manufacturing
2,848
out of 5,505
48th
Major group
Chemicals And Allied Products
1,254
out of 2,375
47th
Industry group
Drugs
1,118
out of 2,096
47th
Industry
Pharmaceutical Preparations
811
out of 1,546
48th
Source: SEC filing on April 8, 2022.

Mason's colleagues

We found five more compensation records of executives who worked with Michael Mason at Karyopharm Therapeutics in 2021.

2021

Richard Paulson

Karyopharm Therapeutics

Chief Executive Officer

2021

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2021

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2021

Jatin Shah

Karyopharm Therapeutics

Chief Medical Officer

2021

Ran Frenkel

Karyopharm Therapeutics

Executive Vice President, Chief Development Officer

News

You may also like